13:35:04 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-17 Kvartalsrapport 2024-Q3
2024-07-12 Kvartalsrapport 2024-Q2
2024-04-19 Ordinarie utdelning ARJO B 0.90 SEK
2024-04-18 Kvartalsrapport 2024-Q1
2024-04-18 Årsstämma 2024
2024-01-30 Bokslutskommuniké 2023
2023-10-19 Kvartalsrapport 2023-Q3
2023-07-13 Kvartalsrapport 2023-Q2
2023-07-12 Kvartalsrapport 2023-Q2
2023-04-21 Ordinarie utdelning ARJO B 0.85 SEK
2023-04-20 Kvartalsrapport 2023-Q1
2023-04-20 Årsstämma 2023
2023-01-25 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-07-14 Kvartalsrapport 2022-Q2
2022-04-25 Ordinarie utdelning ARJO B 1.15 SEK
2022-04-22 Kvartalsrapport 2022-Q1
2022-04-22 Årsstämma 2022
2022-02-03 Bokslutskommuniké 2021
2021-10-28 Kvartalsrapport 2021-Q3
2021-07-15 Kvartalsrapport 2021-Q2
2021-04-28 Ordinarie utdelning ARJO B 0.85 SEK
2021-04-27 Kvartalsrapport 2021-Q1
2021-04-27 Årsstämma 2021
2021-02-03 Bokslutskommuniké 2020
2020-10-28 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-06-30 Ordinarie utdelning ARJO B 0.65 SEK
2020-06-29 Årsstämma 2020
2020-04-27 Kvartalsrapport 2020-Q1
2020-02-04 Bokslutskommuniké 2019
2019-10-22 Kvartalsrapport 2019-Q3
2019-07-18 Kvartalsrapport 2019-Q2
2019-05-08 Ordinarie utdelning ARJO B 0.55 SEK
2019-05-07 Årsstämma 2019
2019-05-07 Kvartalsrapport 2019-Q1
2019-02-04 Bokslutskommuniké 2018
2018-10-22 Kvartalsrapport 2018-Q3
2018-07-19 Kvartalsrapport 2018-Q2
2018-05-07 Ordinarie utdelning ARJO B 0.50 SEK
2018-05-04 Kvartalsrapport 2018-Q1
2018-05-04 Årsstämma 2018
2018-01-29 Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Arjo är ett globalt bolag med verksamhet inom sjukvårdsindustrin. Bolaget är idag specialiserade inom utvecklingen av medicintekniska produkter. Produktportföljen är bred och inkluderar exempelvis sjukvårdssängar, golv- och taklyftar, desinfektionslösningar, samt av hygienprodukter och kompressionslösningar. Utöver erbjuds service och tillhörande tjänster samt utbildning. Störst verksamhet återfinns inom Europa och Nordamerika.
2024-02-29 14:00:00

Arjo's climate targets are in line with the latest climate science and the Paris Agreement. This was confirmed by the Science Based Targets initiative (SBTi), which has now validated the company's climate targets.

"The approval is an important milestone in our sustainability efforts and shows that we have clear targets and a concrete plan to achieve them. We are determined to reduce our climate impact and contribute to the transition to more sustainable healthcare together with our customers and partners," says Joacim Lindoff, President & CEO of Arjo.

Arjo's target is to reduce greenhouse gas (GHG) emissions from its own operations (scope 1 and 2) by 50% by 2030. For the value chain (scope 3), the target is to reduce emissions by 25% by 2030. 2021 is the base year for both targets.

Arjo's GHG emissions from its own operations (Scope 1 and 2) have been reduced by 11% since the base year 2021. A number of initiatives are underway to achieve the targets, focusing on the transition to renewable energy, energy and resource efficiency and the transition to electric vehicles. Arjo is also committed to reducing emissions from the supply chain by collaborating more closely with the Group's suppliers.

For more information, please contact:                                                                                              

Johan Östblad, Head of Sustainability
Tel: +46 (0)73 684 57 45
Email: johan.ostblad@arjo.com

About the Science Based Targets initiative

The Science Based Targets initiative (SBTi) is a partnership between CDP, the United Nations Global Compact, the World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). The SBTi drives ambitious climate action by enabling organizations to set science-based emissions reduction targets in line with the Paris Agreement.

About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With more than 6,500 people worldwide and over 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com